DK0398443T3 - Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae - Google Patents

Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae

Info

Publication number: DK0398443T3
Authority: DK; Denmark
Prior art keywords: compounds; plasmodium malariae; formula; lysine; preparation
Prior art date: 1989-05-19

Application number

DK90201244.2T

Other languages

English (en)

Inventor

Antonello Pessi

Elisabetta Bianchi

Fabio Bonelli

Lorella Chiappinelli

Giudice Giuseppe Del

Original Assignee

Eniricerche Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-19

Filing date

1990-05-16

Publication date

1995-04-03

1989-05-19 Priority claimed from IT8920553A external-priority patent/IT1229765B/it

1990-03-23 Priority claimed from IT19800A external-priority patent/IT1241081B/it

1990-05-16 Application filed by Eniricerche Spa filed Critical Eniricerche Spa

1995-04-03 Application granted granted Critical

1995-04-03 Publication of DK0398443T3 publication Critical patent/DK0398443T3/da

Links

150000001875 compounds Chemical class 0.000 title abstract 4
241000223821 Plasmodium malariae Species 0.000 title abstract 3
229940118768 plasmodium malariae Drugs 0.000 title abstract 3
230000002163 immunogen Effects 0.000 title abstract 2
229940126577 synthetic vaccine Drugs 0.000 title 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 3
-1 poly(L-lysine) Polymers 0.000 abstract 3
235000019766 L-Lysine Nutrition 0.000 abstract 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
239000004472 Lysine Substances 0.000 abstract 2
239000008280 blood Substances 0.000 abstract 2
210000004369 blood Anatomy 0.000 abstract 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
229940124280 l-arginine Drugs 0.000 abstract 1
229920000729 poly(L-lysine) polymer Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK90201244.2T 1989-05-19 1990-05-16 Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae DK0398443T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT8920553A IT1229765B (it)	1989-05-19	1989-05-19	Nuovo costrutto antigenico sintetico e suo impiego in diagnostica.
IT19800A IT1241081B (it)	1990-03-23	1990-03-23	Composti immunogenici e loro impiego per la preparazione di vaccini sintetici geneticamente non ristretti per la determinazione immunoenzimatica di anticorpi anti-sporozoita di plasmodium malariae

Publications (1)

Publication Number	Publication Date
DK0398443T3 true DK0398443T3 (da)	1995-04-03

Family

ID=26327309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90201244.2T DK0398443T3 (da)	1989-05-19	1990-05-16	Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae

Country Status (5)

Country	Link
EP (1)	EP0398443B1 (da)
AT (1)	ATE114158T1 (da)
DE (1)	DE69014150T2 (da)
DK (1)	DK0398443T3 (da)
ES (1)	ES2063901T3 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1198225B (it) *	1986-12-04	1988-12-21	Eniricerche Spa	Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
IT1198233B (it) *	1986-12-23	1988-12-21	Eniricerche Spa	Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano

1990
- 1990-05-16 DE DE69014150T patent/DE69014150T2/de not_active Expired - Fee Related
- 1990-05-16 EP EP90201244A patent/EP0398443B1/en not_active Expired - Lifetime
- 1990-05-16 AT AT90201244T patent/ATE114158T1/de not_active IP Right Cessation
- 1990-05-16 DK DK90201244.2T patent/DK0398443T3/da active
- 1990-05-16 ES ES90201244T patent/ES2063901T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE114158T1 (de)	1994-12-15
EP0398443A1 (en)	1990-11-22
ES2063901T3 (es)	1995-01-16
DE69014150D1 (de)	1994-12-22
EP0398443B1 (en)	1994-11-17
DE69014150T2 (de)	1995-05-11

Similar Documents

Publication	Publication Date	Title
BEY et al.	1987	Decarboxylases Involved in Polyamine Biosynthesis
DK0983342T3 (da)	2008-01-07	Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse
CY1114836T1 (el)	2016-12-14	Παραγωγο δικυκλικου γ-αμινοξεος
EP3805248A3 (en)	2021-07-14	Process for concentration of antibodies and therapeutic products thereof
NO20001052L (no)	2000-04-28	1C, 15N, 2H merkede proteiner for NMR-strukturbestemmelser og deres fremstilling
IT1241395B (it)	1994-01-10	Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
CY1106135T1 (el)	2011-06-08	Μεσο για την ελευθepη απο πρωτεϊνη και ελευθepη απο ορο καλλιεργεια κυτταρων
CA2420350A1 (en)	2002-03-07	Membrane penetrating peptides and uses thereof
RU2015112079A (ru)	2016-12-10	Композиции и способы, имеющие отношение к мутантному токсину из Clostridium Difficile
BR9909775A (pt)	2000-12-19	Amida, uso de amidas e preparação farmacêutica
RU2015147247A (ru)	2017-05-05	Новые соединения, обладающие тройной активностью, тромболизисной, антитромботической и захвата радикалов, и их синтез, наноструктуры и применение
DK0398443T3 (da)	1995-04-03	Immunogene forbindelser samt deres anvendelse til fremstilling af genetisk uindskrænkede syntetiske vacciner og til immunoenzymatisk bestemmelse af antisporozoit-antistoffer mod Plasmodium malariae
CY1113871T1 (el)	2016-07-27	Διαδικασια παρασκευης γκαμπαπεντινης
DK1272633T3 (da)	2011-05-23	Præparater og fremgangsmåder til dendritisk celle-baseret immunterapi
CA2263362A1 (fr)	1998-12-17	Composes bi-aromatiques et compositions pharmaceutiques et cosmetiques les contenant
TR200501541T2 (tr)	2005-06-21	Leu-hirudinin e.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları
EP1194526A4 (en)	2003-07-30	ONE-STEP ALLEL EXCHANGE IN MYCOBACTERIUM BY MEANS OF CONDITIONAL TRANSDUCTIVE PHAGE
EA200501557A1 (ru)	2006-04-28	Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
IT1241081B (it)	1993-12-29	Composti immunogenici e loro impiego per la preparazione di vaccini sintetici geneticamente non ristretti per la determinazione immunoenzimatica di anticorpi anti-sporozoita di plasmodium malariae
DK1197563T3 (da)	2006-07-03	Fremgangsmåde til fremstilling af aminosyrer
HUP0105180A2 (hu)	2002-04-29	Eljárás 2-amino-4-klór-1,3,5-triazin-származékok előállítására
EA200000127A1 (ru)	2000-08-28	Способ получения аминопроизводных алкилоксифуранона, получаемые этим способом соединения и применение этих соединений
AR045516A1 (es)	2005-11-02	Procedimiento para la sintesis de perindopril y de sus sales farmeceuticamente aceptables
DE60015559D1 (de)	2004-12-09	Sentrin-spezifische menschliche protease senp1
AU732445B2 (en)	2001-04-26	Stabilized transient gene expression